Katsuyoshi SUZUKI

Investigating the usefulness of a cluster-based trend analysis to detect visual field progression in patients with open-angle glaucoma.

Cluster-based trend analysis and mTD trend analysis results were significantly associated in all clusters and with all lengths of VF series.

Validating Variational Bayes Linear Regression Method With Multi-Central Datasets.

VBLR outperformed OLSLR to predict future VF progression, and the VBLR has a potential to be a helpful tool at clinical settings.

OCT Signal Enhancement with Deep Learning.

Image enhancement significantly improved the agreement of TD OCT RNFLT measurements with SD OCT RNFLT measurements.

Effects of ocular and systemic factors on the progression of glaucomatous visual field damage in various sectors.

Smoking status is related to glaucomatous VF progression in all sectors of the inferior hemifield.

Imaging Outcomes in Clinical Trials of Treatments for Glaucoma.

Short-term Assessment of Glaucoma Progression in Clinical Trials Using Trend-based Visual Field Progression Analysis.

Glaucoma clinical trial sample sizes vary significantly with disease stage, test frequency, and eye inclusion. Early-stage disease and bilateral eye inclusion reduce required sample sizes, improving trial efficiency.

Evaluation of Glaucoma Progression in Large-Scale Clinical Data: The Japanese Archive of Multicentral Databases in Glaucoma (JAMDIG).

Age and the degree of VF damage were related to future progression.

Safety and Efficacy of Benzalkonium Chloride-optimized Tafluprost in Japanese Glaucoma Patients With Existing Superficial Punctate Keratitis.

BAK-optimized tafluprost is a treatment option to improve the condition of the ocular surface and to maintain IOP control in glaucoma patients with existing SPK who have been previously treated with other BAK-preserved prostaglandin analogs.